A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee
NCT ID: NCT00420992
Last Updated: 2013-09-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
547 participants
INTERVENTIONAL
2006-12-31
2007-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ALO-01
Up to 80 mg twice a day (bid)
ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release)
capsules, up to 80 mg bid
Placebo
Twice a day (bid)
Placebo
capsules, bid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release)
capsules, up to 80 mg bid
Placebo
capsules, bid
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is either not of childbearing potential OR subject must use an acceptable method of birth control if of childbearing potential
* Negative pregnancy test if female of childbearing potential
* Subject is in general good health
* Subject required treatment of joint pain within the last 90 days
* Subject has primary diagnosis of osteoarthritis (OA) of the hip or knee
Exclusion Criteria
* Subject is pregnant or breast-feeding
* Subject is receiving systemic chemotherapy
* Subject has a history of drug abuse/dependence/misuse or alcohol abuse/dependence
* Subject has history of major depressive disorder not controlled with medication
* Subject has any chronic pain syndrome (i.e., fibromyalgia) that may interfere with the symptoms of OA
* Subject has active gastrointestinal disease, with the exception of gastroesophageal reflux disease (GERD)
* Subject has a documented history of rheumatoid arthritis, uncontrolled inflammatory arthritis or non-steroidal anti-inflammatory drug (NSAID)-dependent inflammatory arthritis
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James B. Jones, MD, PharmD
Role: STUDY_DIRECTOR
Alpharma Pharmceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Birmingham Pain Center
Birmingham, Alabama, United States
Horizon Research Group
Mobile, Alabama, United States
Arizona Center for Clinical Research
Peoria, Arizona, United States
Arizona Research Center, Inc
Phoenix, Arizona, United States
Premiere Pharmaceutical Research, LLC
Tempe, Arizona, United States
Advanced Clinical Research Institute
Anaheim, California, United States
Orange County Clinical Trials
Anaheim, California, United States
STAT-CARE / Crest Clinical Trials
Anaheim, California, United States
Southbay Pharma Research
Buena Park, California, United States
Providence Clinical Res. (C-trials)
Burbank, California, United States
Med Investigators Inc
Fair Oaks, California, United States
Quality of Life Medical Center, LLC
Hawaiian Gardens, California, United States
NervePro Research
Irvine, California, United States
UCSD Pain and Palliative Care
La Jolla, California, United States
USCD Pain and Palliative Care
La Jolla, California, United States
Private Practice
Pico Rivera, California, United States
Pain Institute of Santa Monica
Santa Monica, California, United States
Boling Clinical Trials
Upland, California, United States
Mountain View Clinical Research, Inc
Denver, Colorado, United States
Stamford Therapeutics Consortium
Stamford, Connecticut, United States
New England Research Associates, LLC
Trumbull, Connecticut, United States
MD Clinical
Hallandale, Florida, United States
Eastern Research
Hialeah, Florida, United States
Florida Institute of Medical Research
Jacksonville, Florida, United States
Drug Study Institiute
Jupiter, Florida, United States
FPA Clinical Research
Kissimmee, Florida, United States
Innovative Research of West Florida
Largo, Florida, United States
Pharmaceutical Research Associates Inc
Merritt Island, Florida, United States
Ormond Medical Arts - Pharmaceutical Research Center
Ormond Beach, Florida, United States
University Clinical Research, Inc
Pembroke Pines, Florida, United States
Coastal Medical Research
Port Orange, Florida, United States
Stedman Clinical Trials
Tampa, Florida, United States
Gold Coast Research LLC
Weston, Florida, United States
River Birch Research Alliance
Blue Ridge, Georgia, United States
Best Clinical Research
Decatur, Georgia, United States
Non-Surgical Orthopaedic and Spine Center
Marietta, Georgia, United States
Drug Studies America
Marietta, Georgia, United States
Northwest Clinical Trials
Boise, Idaho, United States
Research Associates of Central Illinois
Peoria, Illinois, United States
MediSphere Medical Research Center, LLC
Evansville, Indiana, United States
Welborn Clinic
Newburgh, Indiana, United States
International Clinical Research Institute, Inc
Overland Park, Kansas, United States
Clinical Trials Management, LLC
Mandeville, Louisiana, United States
Lousiana Research Associates Inc.
New Orleans, Louisiana, United States
Internal Research Center
Towson, Maryland, United States
Phase III Clinical Research
Fall River, Massachusetts, United States
Northeast Medical Research Associates, Inc
No Dartmouth, Massachusetts, United States
FutureCare Studies
Springfield, Massachusetts, United States
Synergy Medical Education Alliance
Saginaw, Michigan, United States
Medex Healthcare Research Inc
St Louis, Missouri, United States
Lovelace Scientific
Henderson, Nevada, United States
Advanced Biomedical Research of America
Las Vegas, Nevada, United States
Partners in Primary Care
Voorhees Township, New Jersey, United States
Elkind Headache Center
Mount Vernon, New York, United States
The Arthritis Clinic and Carolina Bone and Joint
Charlotte, North Carolina, United States
The Center for Clinical Research, LLC
Winston-Salem, North Carolina, United States
Community Research
Cincinnati, Ohio, United States
Community Research
Cincinnati, Ohio, United States
Clinical Research Source, Inc
Toledo, Ohio, United States
COR Clinical Research
Oklahoma City, Oklahoma, United States
Health Research Institute
Oklahoma City, Oklahoma, United States
Cutting Edge Research
Oklahoma City, Oklahoma, United States
Tulsa Clinical Research
Tulsa, Oklahoma, United States
LVH Neurosciences and Pain Research
Allentown, Pennsylvania, United States
Pennsylvania Research Institute
Bensalem, Pennsylvania, United States
Altoona Center for Clinical Research
Duncansville, Pennsylvania, United States
Commonwealth Primary Care / Fleetwood Clinical Research
Fleetwood, Pennsylvania, United States
Pivotal Clinical Research, LLC
Souderton, Pennsylvania, United States
Tipton Medical and Diagnostic Center
Tipton, Pennsylvania, United States
Premier Medical Group
Clarksville, Tennessee, United States
SCRI
Cordova, Tennessee, United States
Comprehensive Pain Specialists
Hendersonville, Tennessee, United States
SCRI
Memphis, Tennessee, United States
Integrity Clinical Research, LLC
Milan, Tennessee, United States
Walter F. Chase, MD, PA
Austin, Texas, United States
InSite Clinical Research
DeSoto, Texas, United States
Team Research of Central Texas
Killeen, Texas, United States
Radiant Research, San Antonio Northeast
San Antonio, Texas, United States
North San Antonio Healthcare Associates
San Antonio, Texas, United States
Progressive Clinical Research
San Antonio, Texas, United States
HypotheTest, LLC
Roanoke, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Setnik B, Pixton GC, Webster LR. Safety profile of extended-release morphine sulfate with sequestered naltrexone hydrochloride in older patients: pooled analysis of three clinical trials. Curr Med Res Opin. 2016;32(3):563-72. doi: 10.1185/03007995.2015.1131153. Epub 2016 Jan 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ALO-KNT-301
Identifier Type: -
Identifier Source: org_study_id